BReAst Carcinoma Subtyping (BRACS) dataset, a large cohort of annotated Hematoxylin & Eosin (H&E)-stained images to facilitate the characterization of breast lesions. BRACS contains 547 Whole-Slide Images (WSIs), and 4539 Regions of Interest (ROIs) extracted from the WSIs. Each WSI, and respective ROIs, are annotated by the consensus of three board-certified pathologists into different lesion categories. Specifically, BRACS includes three lesion types, i.e., benign, malignant and atypical, which are further subtyped into seven categories.
6 PAPERS • NO BENCHMARKS YET
The evaluation of human epidermal growth factor receptor 2 (HER2) expression is essential to formulate a precise treatment for breast cancer. The routine evaluation of HER2 is conducted with immunohistochemical techniques (IHC), which is very expensive. Therefore, we propose a breast cancer immunohistochemical (BCI) benchmark attempting to synthesize IHC data directly with the paired hematoxylin and eosin (HE) stained images. The dataset contains 4870 registered image pairs, covering a variety of HER2 expression levels (0, 1+, 2+, 3+).
5 PAPERS • 1 BENCHMARK
This CBIS-DDSM (Curated Breast Imaging Subset of DDSM) is an updated and standardized version of the Digital Database for Screening Mammography (DDSM) . The DDSM is a database of 2,620 scanned film mammography studies. It contains normal, benign, and malignant cases with verified pathology information. The scale of the database along with ground truth validation makes the DDSM a useful tool in the development and testing of decision support systems. The CBIS-DDSM collection includes a subset of the DDSM data selected and curated by a trained mammographer. The images have been decompressed and converted to DICOM format. Updated ROI segmentation and bounding boxes, and pathologic diagnosis for training data are also included. A manuscript describing how to use this dataset in detail is available at https://www.nature.com/articles/sdata2017177.
4 PAPERS • NO BENCHMARKS YET
The breast lesion detection in ultrasound videos dataset uses a clip-level and video-level feature aggregated network (CVA-Net) and consists of 188 ultrasound videos, of which 113 are labeled malignant and 75 benign. Overall these consist of 25,272 ultrasound images in total with the number of images for each video varying from 28 to 413. 150 videos were used for training, 38 for testing. The primary intended use case would be for computer-aided breast cancer diagnosis, supporting systems to assist radiologists.
2 PAPERS • NO BENCHMARKS YET
Several datasets are fostering innovation in higher-level functions for everyone, everywhere. By providing this repository, we hope to encourage the research community to focus on hard problems. In this repository, we present the real results severity (BIRADS) and pathology (post-report) classifications provided by the Radiologist Director from the Radiology Department of Hospital Fernando Fonseca while diagnosing several patients (see dataset-uta4-dicom) from our User Tests and Analysis 4 (UTA4) study. Here, we provide a dataset for the measurements of both severity (BIRADS) and pathology classifications concerning the patient diagnostic. Work and results are published on a top Human-Computer Interaction (HCI) conference named AVI 2020 (page). Results were analyzed and interpreted from our Statistical Analysis charts. The user tests were made in clinical institutions, where clinicians diagnose several patients for a Single-Modality vs Multi-Modality comparison. For example, in these t
1 PAPER • NO BENCHMARKS YET
Breast carcinoma is the second largest cancer in the world among women. Early detection of breast cancer has been shown to increase the survival rate, thereby significantly increasing patients' lifespans. Mammography, a noninvasive imaging tool with low cost, is widely used to diagnose breast disease at an early stage due to its high sensitivity. The recent popularization of artificial intelligence in computer-aided diagnosis creates opportunities for advances in areas such as (1) Computer-aided detection for locating suspect lesions such as mass and microcalcification, leaving the classification to the radiologist; and (2) Computer-aided diagnosis for characterizing the suspicious region of lesion and/or estimate its probability of onset; and (3) Findings of predictive image-based biomarkers by applying the computational methods to mine the potential relationships between image representation and molecular subtype, including luminal A, luminal B, HER2 positive, and Triple-negative.
1 PAPER • 1 BENCHMARK